Jørgen Vestbo Selected Research

Salmeterol Xinafoate (Serevent)

1/2018	Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.
1/2016	Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
1/2011	Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study.
8/2010	Cardiovascular events in patients with COPD: TORCH study results.
12/2009	Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
8/2008	Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
9/2007	[Salmeterol and fluticason and mortality in COPD patients].
2/2007	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
11/2004	Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.
1/2004	[Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jørgen Vestbo Research Topics

Disease

208	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 08/2002
20	Asthma (Bronchial Asthma) 01/2024 - 09/2004
19	Emphysema 01/2021 - 12/2009
18	Inflammation (Inflammations) 01/2024 - 09/2004
15	Pneumonia (Pneumonitis) 01/2021 - 02/2007
11	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2013
9	Dyspnea (Shortness of Breath) 01/2024 - 09/2005
7	Obstructive Lung Diseases (Obstructive Lung Disease) 02/2019 - 03/2011
5	Respiratory Insufficiency (Respiratory Failure) 10/2020 - 01/2013
4	Lung Diseases (Lung Disease) 10/2023 - 09/2005
4	Disease Progression 01/2022 - 08/2008
4	Fatigue 12/2016 - 01/2011
3	Myocardial Infarction 10/2017 - 11/2012
2	Cough 03/2023 - 05/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 08/2002
2	COVID-19 12/2020 - 10/2020
2	Fibrosis (Cirrhosis) 07/2020 - 10/2011
2	Heart Failure 01/2017 - 11/2012
2	Gastroesophageal Reflux (GERD) 09/2015 - 01/2015
2	Chronic Disease (Chronic Diseases) 08/2015 - 08/2012
2	Lung Neoplasms (Lung Cancer) 05/2015 - 11/2012
2	Pulmonary Embolism 11/2012 - 09/2005
1	Mycoses (Diseases, Fungus) 01/2024
1	Overweight 07/2023
1	Venous Thromboembolism 07/2023
1	Thromboembolism 07/2023
1	Hypertension (High Blood Pressure) 07/2023

Drug/Important Bio-Agent (IBA)

60	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2009
49	GoldIBA 02/2024 - 08/2002
46	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2003
23	Bronchodilator Agents (Bronchodilators)IBA 01/2024 - 01/2003
20	fluticasone furoate FDA Link 01/2020 - 05/2013
20	vilanterolIBA 01/2020 - 05/2013
11	Proteins (Proteins, Gene)FDA Link 04/2019 - 01/2009
11	Salmeterol Xinafoate (Serevent)FDA Link 01/2018 - 02/2003
10	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 02/2003
10	C-Reactive ProteinIBA 01/2018 - 02/2007
9	Fibrinogen (Factor I)FDA Link 11/2019 - 01/2012
8	Oxygen (Dioxygen)IBA 10/2020 - 09/2003
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2009
7	Formoterol Fumarate (Oxis)FDA Link 01/2018 - 01/2013
6	SteroidsIBA 06/2023 - 03/2007
6	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2021 - 12/2012
6	Muscarinic AntagonistsIBA 01/2020 - 10/2010
6	Beclomethasone (Beclometasone)FDA Link 01/2018 - 01/2013
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 08/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2009
5	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018 - 01/2016
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024 - 09/2011
4	SmokeIBA 01/2021 - 12/2009
4	Interleukin-8 (Interleukin 8)IBA 01/2018 - 05/2009
4	Tiotropium Bromide (Spiriva)FDA Link 05/2017 - 10/2010
3	Prednisolone (Predate)FDA LinkGeneric 07/2023 - 01/2017
3	von Willebrand FactorIBA 08/2022 - 01/2020
3	FibrinIBA 08/2022 - 11/2019
3	GasesIBA 01/2022 - 03/2014
3	EnzymesIBA 01/2021 - 09/2004
3	CytokinesIBA 01/2021 - 01/2021
3	prednylidene (Pred)IBA 01/2018 - 08/2014
3	indacaterolIBA 01/2018 - 01/2016
3	Vitamin D FDA LinkGeneric 08/2014 - 10/2013
2	insulin receptor-related receptor (IRR)IBA 01/2023 - 01/2021
2	Immunoglobulin E (IgE)IBA 10/2022 - 02/2006
2	GlucocorticoidsIBA 01/2022 - 01/2016
2	Dihydrotachysterol (AT 10)IBA 07/2021 - 01/2017
2	InterleukinsIBA 01/2021 - 08/2014
2	ElastinIBA 11/2019 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2018 - 08/2002
2	CollagenIBA 12/2017 - 10/2016
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2017 - 09/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2016 - 01/2015
2	CalciumIBA 01/2016 - 08/2014
2	AcidsIBA 09/2015 - 01/2015
1	Interleukin-10 (Interleukin 10)IBA 10/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2023
1	Bendroflumethiazide (Naturetin)FDA LinkGeneric 07/2023
1	Amlodipine (Norvasc)FDA LinkGeneric 07/2023
1	AnticoagulantsIBA 06/2023
1	Fibrin Fibrinogen Degradation ProductsIBA 06/2023
1	fibrin fragment D (D-dimer)IBA 06/2023
1	Biosimilar PharmaceuticalsIBA 06/2023
1	Expectorants (Mucolytics)IBA 03/2023
1	Carbon MonoxideIBA 12/2022
1	Omalizumab (Xolair)FDA Link 10/2022
1	Immunoglobulins (Immunoglobulin)IBA 10/2022
1	omega-Chloroacetophenone (Mace)IBA 08/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	ferric oxide (iron oxide)IBA 10/2021

Therapy/Procedure

43	Therapeutics 07/2021 - 11/2004
6	Nebulizers and Vaporizers (Inhaler) 01/2019 - 01/2013
4	Drug Therapy (Chemotherapy) 12/2023 - 08/2008
3	Noninvasive Ventilation 11/2014 - 01/2013
2	Length of Stay 03/2023 - 05/2021
2	Precision Medicine 01/2021 - 02/2016
2	Critical Care (Surgical Intensive Care) 12/2016 - 01/2013
2	Dry Powder Inhalers 12/2015 - 09/2015
2	Patient Readmission 08/2005 - 01/2003
1	Aftercare (After-Treatment) 01/2022
1	Activities of Daily Living (ADL) 01/2022
1	Patient Care Bundles 07/2021